nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—SLC22A4—ulcerative colitis	0.317	0.571	CbGaD
Ofloxacin—SLC22A5—ulcerative colitis	0.239	0.429	CbGaD
Ofloxacin—SLC22A4—Nicotine—ulcerative colitis	0.115	0.446	CbGbCtD
Ofloxacin—SLC22A5—Nicotine—ulcerative colitis	0.0649	0.252	CbGbCtD
Ofloxacin—ABCC2—Sulfasalazine—ulcerative colitis	0.0393	0.153	CbGbCtD
Ofloxacin—ABCC2—Dexamethasone—ulcerative colitis	0.0196	0.0762	CbGbCtD
Ofloxacin—CYP1A2—Nicotine—ulcerative colitis	0.0188	0.0732	CbGbCtD
Ofloxacin—ABCC2—bile duct—ulcerative colitis	0.00447	0.438	CbGeAlD
Ofloxacin—SLC22A4—Organic cation transport—SLC22A5—ulcerative colitis	0.00386	0.136	CbGpPWpGaD
Ofloxacin—ABCC2—bile—ulcerative colitis	0.00343	0.336	CbGeAlD
Ofloxacin—SLC22A5—Organic cation transport—SLC22A4—ulcerative colitis	0.0029	0.102	CbGpPWpGaD
Ofloxacin—SLC22A4—Organic cation/anion/zwitterion transport—SLC22A5—ulcerative colitis	0.00262	0.0919	CbGpPWpGaD
Ofloxacin—SLC22A5—Organic cation/anion/zwitterion transport—SLC22A4—ulcerative colitis	0.00197	0.0691	CbGpPWpGaD
Ofloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—ulcerative colitis	0.00149	0.0521	CbGpPWpGaD
Ofloxacin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—ulcerative colitis	0.00149	0.0521	CbGpPWpGaD
Ofloxacin—Sparfloxacin—SLC22A5—ulcerative colitis	0.000778	0.228	CrCbGaD
Ofloxacin—ABCC2—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000761	0.0267	CbGpPWpGaD
Ofloxacin—Levofloxacin—SLC22A4—ulcerative colitis	0.000728	0.213	CrCbGaD
Ofloxacin—ABCC1—Sphingosine 1-phosphate (S1P) pathway—GNA12—ulcerative colitis	0.000642	0.0225	CbGpPWpGaD
Ofloxacin—Lomefloxacin—SLC22A5—ulcerative colitis	0.00064	0.188	CrCbGaD
Ofloxacin—TOP2A—Methyldopa—Mesalazine—ulcerative colitis	0.000543	0.421	CbGdCrCtD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.000524	0.0184	CbGpPWpGaD
Ofloxacin—ABCC2—NRF2 pathway—SLC39A11—ulcerative colitis	0.000465	0.0163	CbGpPWpGaD
Ofloxacin—Norfloxacin—SLC22A5—ulcerative colitis	0.000444	0.13	CrCbGaD
Ofloxacin—SLC22A4—digestive system—ulcerative colitis	0.000439	0.043	CbGeAlD
Ofloxacin—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000416	0.0146	CbGpPWpGaD
Ofloxacin—ABCC2—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.000415	0.0146	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000404	0.0142	CbGpPWpGaD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.000394	0.0138	CbGpPWpGaD
Ofloxacin—ABCC2—digestive system—ulcerative colitis	0.000375	0.0367	CbGeAlD
Ofloxacin—Gatifloxacin—ALB—ulcerative colitis	0.000331	0.0969	CrCbGaD
Ofloxacin—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.000327	0.0115	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000304	0.0107	CbGpPWpGaD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—ulcerative colitis	0.000298	0.0104	CbGpPWpGaD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—ulcerative colitis	0.000298	0.0104	CbGpPWpGaD
Ofloxacin—SLC22A5—digestive system—ulcerative colitis	0.00029	0.0285	CbGeAlD
Ofloxacin—ABCC2—liver—ulcerative colitis	0.000279	0.0274	CbGeAlD
Ofloxacin—CYP1A2—digestive system—ulcerative colitis	0.000263	0.0258	CbGeAlD
Ofloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—ulcerative colitis	0.000263	0.00923	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000262	0.00919	CbGpPWpGaD
Ofloxacin—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000251	0.00881	CbGpPWpGaD
Ofloxacin—ABCC1—Arachidonic acid metabolism—PTGS1—ulcerative colitis	0.000248	0.0087	CbGpPWpGaD
Ofloxacin—ABCC1—liver—ulcerative colitis	0.000246	0.0241	CbGeAlD
Ofloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.000246	0.00862	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000239	0.00839	CbGpPWpGaD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000239	0.00837	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000238	0.00837	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC26A3—ulcerative colitis	0.000229	0.00805	CbGpPWpGaD
Ofloxacin—ABCC2—ABC-family proteins mediated transport—ABCB1—ulcerative colitis	0.000228	0.00802	CbGpPWpGaD
Ofloxacin—ABCC1—ABC-family proteins mediated transport—ABCB1—ulcerative colitis	0.000226	0.00792	CbGpPWpGaD
Ofloxacin—SLC22A5—liver—ulcerative colitis	0.000216	0.0212	CbGeAlD
Ofloxacin—ABCC1—S1P1 pathway—PTGS2—ulcerative colitis	0.000206	0.00723	CbGpPWpGaD
Ofloxacin—Sparfloxacin—ABCB1—ulcerative colitis	0.000206	0.0603	CrCbGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000205	0.00721	CbGpPWpGaD
Ofloxacin—CYP1A2—liver—ulcerative colitis	0.000196	0.0192	CbGeAlD
Ofloxacin—TOP2A—Methyltestosterone—Hydrocortisone—ulcerative colitis	0.000193	0.15	CbGdCrCtD
Ofloxacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—ulcerative colitis	0.000185	0.00651	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000179	0.00629	CbGpPWpGaD
Ofloxacin—TOP2A—Methyltestosterone—Prednisone—ulcerative colitis	0.000166	0.129	CbGdCrCtD
Ofloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000166	0.00584	CbGpPWpGaD
Ofloxacin—TOP2A—Methyltestosterone—Prednisolone—ulcerative colitis	0.000162	0.126	CbGdCrCtD
Ofloxacin—TOP2A—Cell Cycle, Mitotic—CEP72—ulcerative colitis	0.000157	0.00552	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000154	0.00542	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000148	0.00521	CbGpPWpGaD
Ofloxacin—Levofloxacin—ABCB1—ulcerative colitis	0.000145	0.0425	CrCbGaD
Ofloxacin—TOP2A—Cell Cycle—CEP72—ulcerative colitis	0.000141	0.00493	CbGpPWpGaD
Ofloxacin—Ciprofloxacin—ABCB1—ulcerative colitis	0.00014	0.041	CrCbGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	0.000137	0.00483	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—ulcerative colitis	0.000135	0.00475	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—ulcerative colitis	0.000135	0.00475	CbGpPWpGaD
Ofloxacin—TOP2A—Norethindrone—Hydrocortisone—ulcerative colitis	0.000126	0.0975	CbGdCrCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	0.000121	0.00425	CbGpPWpGaD
Ofloxacin—TOP2A—Gastric Cancer Network 2—TP53—ulcerative colitis	0.00012	0.0042	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000117	0.00409	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000113	0.00396	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	0.000112	0.00392	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	0.000112	0.00392	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—GHRL—ulcerative colitis	0.000109	0.00384	CbGpPWpGaD
Ofloxacin—TOP2A—Levonorgestrel—Hydrocortisone—ulcerative colitis	0.0001	0.0776	CbGdCrCtD
Ofloxacin—ABCC1—Arachidonic acid metabolism—PTGS2—ulcerative colitis	9.5e-05	0.00333	CbGpPWpGaD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS1—ulcerative colitis	9.41e-05	0.0033	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—ulcerative colitis	9.35e-05	0.00328	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	9.1e-05	0.0032	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	8.97e-05	0.00315	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	8.95e-05	0.00314	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	8.58e-05	0.00301	CbGpPWpGaD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—ulcerative colitis	8.42e-05	0.00296	CbGpPWpGaD
Ofloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	8.26e-05	0.0029	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	7.54e-05	0.00265	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	6.87e-05	0.00241	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	6.87e-05	0.00241	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	6.66e-05	0.00234	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	6.66e-05	0.00234	CbGpPWpGaD
Ofloxacin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	6.59e-05	0.00231	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	6.58e-05	0.00231	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	6.58e-05	0.00231	CbGpPWpGaD
Ofloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	6.24e-05	0.00219	CbGpPWpGaD
Ofloxacin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—ulcerative colitis	6.1e-05	0.00214	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—PPARG—ulcerative colitis	5.73e-05	0.00201	CbGpPWpGaD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	5.67e-05	0.00199	CbGpPWpGaD
Ofloxacin—SLC22A4—SLC-mediated transmembrane transport—ALB—ulcerative colitis	5.34e-05	0.00188	CbGpPWpGaD
Ofloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ulcerative colitis	5.24e-05	0.00184	CbGpPWpGaD
Ofloxacin—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	4.84e-05	0.0017	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	4.7e-05	0.00165	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CHP1—ulcerative colitis	4.51e-05	0.00158	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	4.34e-05	0.00152	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	4.28e-05	0.0015	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	4.15e-05	0.00146	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	4.1e-05	0.00144	CbGpPWpGaD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	4.08e-05	0.00143	CbGpPWpGaD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	4.05e-05	0.00142	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	4.02e-05	0.00141	CbGpPWpGaD
Ofloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—ulcerative colitis	4.02e-05	0.00141	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	3.97e-05	0.00139	CbGpPWpGaD
Ofloxacin—Nervous system disorder—Hydrocortisone—ulcerative colitis	3.96e-05	0.000277	CcSEcCtD
Ofloxacin—Myalgia—Methylprednisolone—ulcerative colitis	3.95e-05	0.000276	CcSEcCtD
Ofloxacin—Arthralgia—Methylprednisolone—ulcerative colitis	3.95e-05	0.000276	CcSEcCtD
Ofloxacin—Eye disorder—Prednisone—ulcerative colitis	3.95e-05	0.000276	CcSEcCtD
Ofloxacin—Anxiety—Methylprednisolone—ulcerative colitis	3.94e-05	0.000275	CcSEcCtD
Ofloxacin—Tachycardia—Hydrocortisone—ulcerative colitis	3.94e-05	0.000275	CcSEcCtD
Ofloxacin—Rash—Azathioprine—ulcerative colitis	3.93e-05	0.000274	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	3.93e-05	0.000274	CcSEcCtD
Ofloxacin—Dermatitis—Azathioprine—ulcerative colitis	3.92e-05	0.000274	CcSEcCtD
Ofloxacin—Flushing—Prednisone—ulcerative colitis	3.92e-05	0.000274	CcSEcCtD
Ofloxacin—Skin disorder—Hydrocortisone—ulcerative colitis	3.92e-05	0.000274	CcSEcCtD
Ofloxacin—Ill-defined disorder—Dexamethasone—ulcerative colitis	3.92e-05	0.000274	CcSEcCtD
Ofloxacin—Ill-defined disorder—Betamethasone—ulcerative colitis	3.92e-05	0.000274	CcSEcCtD
Ofloxacin—Discomfort—Triamcinolone—ulcerative colitis	3.92e-05	0.000274	CcSEcCtD
Ofloxacin—Discomfort—Methylprednisolone—ulcerative colitis	3.91e-05	0.000273	CcSEcCtD
Ofloxacin—Headache—Azathioprine—ulcerative colitis	3.9e-05	0.000273	CcSEcCtD
Ofloxacin—Hyperhidrosis—Hydrocortisone—ulcerative colitis	3.9e-05	0.000273	CcSEcCtD
Ofloxacin—Diarrhoea—Mesalazine—ulcerative colitis	3.88e-05	0.000271	CcSEcCtD
Ofloxacin—Dry mouth—Triamcinolone—ulcerative colitis	3.88e-05	0.000271	CcSEcCtD
Ofloxacin—Angioedema—Dexamethasone—ulcerative colitis	3.86e-05	0.00027	CcSEcCtD
Ofloxacin—Angioedema—Betamethasone—ulcerative colitis	3.86e-05	0.00027	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	3.86e-05	0.00135	CbGpPWpGaD
Ofloxacin—Anorexia—Hydrocortisone—ulcerative colitis	3.85e-05	0.000269	CcSEcCtD
Ofloxacin—Angiopathy—Prednisone—ulcerative colitis	3.83e-05	0.000268	CcSEcCtD
Ofloxacin—Confusional state—Methylprednisolone—ulcerative colitis	3.82e-05	0.000267	CcSEcCtD
Ofloxacin—Immune system disorder—Prednisone—ulcerative colitis	3.82e-05	0.000267	CcSEcCtD
Ofloxacin—Malaise—Betamethasone—ulcerative colitis	3.81e-05	0.000266	CcSEcCtD
Ofloxacin—Malaise—Dexamethasone—ulcerative colitis	3.81e-05	0.000266	CcSEcCtD
Ofloxacin—Oedema—Triamcinolone—ulcerative colitis	3.8e-05	0.000266	CcSEcCtD
Ofloxacin—Anaphylactic shock—Triamcinolone—ulcerative colitis	3.8e-05	0.000266	CcSEcCtD
Ofloxacin—Vertigo—Betamethasone—ulcerative colitis	3.8e-05	0.000265	CcSEcCtD
Ofloxacin—Vertigo—Dexamethasone—ulcerative colitis	3.8e-05	0.000265	CcSEcCtD
Ofloxacin—Anaphylactic shock—Methylprednisolone—ulcerative colitis	3.79e-05	0.000265	CcSEcCtD
Ofloxacin—Syncope—Dexamethasone—ulcerative colitis	3.79e-05	0.000265	CcSEcCtD
Ofloxacin—Syncope—Betamethasone—ulcerative colitis	3.79e-05	0.000265	CcSEcCtD
Ofloxacin—ABCC1—Metabolism—CHP1—ulcerative colitis	3.78e-05	0.00133	CbGpPWpGaD
Ofloxacin—Arrhythmia—Prednisone—ulcerative colitis	3.78e-05	0.000264	CcSEcCtD
Ofloxacin—Infection—Triamcinolone—ulcerative colitis	3.77e-05	0.000264	CcSEcCtD
Ofloxacin—Hypotension—Hydrocortisone—ulcerative colitis	3.77e-05	0.000263	CcSEcCtD
Ofloxacin—Infection—Methylprednisolone—ulcerative colitis	3.77e-05	0.000263	CcSEcCtD
Ofloxacin—Dizziness—Mesalazine—ulcerative colitis	3.75e-05	0.000262	CcSEcCtD
Ofloxacin—Shock—Triamcinolone—ulcerative colitis	3.74e-05	0.000261	CcSEcCtD
Ofloxacin—Insomnia—Prednisolone—ulcerative colitis	3.74e-05	0.000261	CcSEcCtD
Ofloxacin—Alopecia—Prednisone—ulcerative colitis	3.73e-05	0.000261	CcSEcCtD
Ofloxacin—Shock—Methylprednisolone—ulcerative colitis	3.73e-05	0.000261	CcSEcCtD
Ofloxacin—Nervous system disorder—Methylprednisolone—ulcerative colitis	3.72e-05	0.00026	CcSEcCtD
Ofloxacin—Loss of consciousness—Dexamethasone—ulcerative colitis	3.71e-05	0.000259	CcSEcCtD
Ofloxacin—Loss of consciousness—Betamethasone—ulcerative colitis	3.71e-05	0.000259	CcSEcCtD
Ofloxacin—Paraesthesia—Prednisolone—ulcerative colitis	3.71e-05	0.000259	CcSEcCtD
Ofloxacin—Tachycardia—Triamcinolone—ulcerative colitis	3.71e-05	0.000259	CcSEcCtD
Ofloxacin—Mental disorder—Prednisone—ulcerative colitis	3.7e-05	0.000259	CcSEcCtD
Ofloxacin—Nausea—Azathioprine—ulcerative colitis	3.7e-05	0.000259	CcSEcCtD
Ofloxacin—Tachycardia—Methylprednisolone—ulcerative colitis	3.7e-05	0.000259	CcSEcCtD
Ofloxacin—Skin disorder—Methylprednisolone—ulcerative colitis	3.68e-05	0.000257	CcSEcCtD
Ofloxacin—Erythema—Prednisone—ulcerative colitis	3.68e-05	0.000257	CcSEcCtD
Ofloxacin—Malnutrition—Prednisone—ulcerative colitis	3.68e-05	0.000257	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	3.68e-05	0.000257	CcSEcCtD
Ofloxacin—Hyperhidrosis—Triamcinolone—ulcerative colitis	3.67e-05	0.000257	CcSEcCtD
Ofloxacin—Hyperhidrosis—Methylprednisolone—ulcerative colitis	3.66e-05	0.000256	CcSEcCtD
Ofloxacin—Insomnia—Hydrocortisone—ulcerative colitis	3.65e-05	0.000255	CcSEcCtD
Ofloxacin—Hypertension—Betamethasone—ulcerative colitis	3.65e-05	0.000255	CcSEcCtD
Ofloxacin—Hypertension—Dexamethasone—ulcerative colitis	3.65e-05	0.000255	CcSEcCtD
Ofloxacin—Paraesthesia—Hydrocortisone—ulcerative colitis	3.62e-05	0.000253	CcSEcCtD
Ofloxacin—Vomiting—Mesalazine—ulcerative colitis	3.61e-05	0.000252	CcSEcCtD
Ofloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	3.61e-05	0.00127	CbGpPWpGaD
Ofloxacin—Myalgia—Dexamethasone—ulcerative colitis	3.6e-05	0.000251	CcSEcCtD
Ofloxacin—Myalgia—Betamethasone—ulcerative colitis	3.6e-05	0.000251	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	3.59e-05	0.00126	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SEL1L—ulcerative colitis	3.58e-05	0.00126	CbGpPWpGaD
Ofloxacin—Anxiety—Dexamethasone—ulcerative colitis	3.58e-05	0.00025	CcSEcCtD
Ofloxacin—Anxiety—Betamethasone—ulcerative colitis	3.58e-05	0.00025	CcSEcCtD
Ofloxacin—Rash—Mesalazine—ulcerative colitis	3.58e-05	0.00025	CcSEcCtD
Ofloxacin—Dermatitis—Mesalazine—ulcerative colitis	3.57e-05	0.00025	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	3.57e-05	0.00125	CbGpPWpGaD
Ofloxacin—Headache—Mesalazine—ulcerative colitis	3.55e-05	0.000248	CcSEcCtD
Ofloxacin—Discomfort—Betamethasone—ulcerative colitis	3.55e-05	0.000248	CcSEcCtD
Ofloxacin—Discomfort—Dexamethasone—ulcerative colitis	3.55e-05	0.000248	CcSEcCtD
Ofloxacin—Dyspepsia—Hydrocortisone—ulcerative colitis	3.55e-05	0.000248	CcSEcCtD
Ofloxacin—Hypotension—Methylprednisolone—ulcerative colitis	3.54e-05	0.000248	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.54e-05	0.00124	CbGpPWpGaD
Ofloxacin—Pain—Prednisolone—ulcerative colitis	3.53e-05	0.000247	CcSEcCtD
Ofloxacin—Decreased appetite—Hydrocortisone—ulcerative colitis	3.51e-05	0.000245	CcSEcCtD
Ofloxacin—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	3.5e-05	0.00123	CbGpPWpGaD
Ofloxacin—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	3.48e-05	0.000243	CcSEcCtD
Ofloxacin—Fatigue—Hydrocortisone—ulcerative colitis	3.48e-05	0.000243	CcSEcCtD
Ofloxacin—Vision blurred—Prednisone—ulcerative colitis	3.47e-05	0.000242	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	3.46e-05	0.000242	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	3.45e-05	0.000241	CcSEcCtD
Ofloxacin—Pain—Hydrocortisone—ulcerative colitis	3.45e-05	0.000241	CcSEcCtD
Ofloxacin—Oedema—Betamethasone—ulcerative colitis	3.45e-05	0.000241	CcSEcCtD
Ofloxacin—Oedema—Dexamethasone—ulcerative colitis	3.45e-05	0.000241	CcSEcCtD
Ofloxacin—Anaphylactic shock—Betamethasone—ulcerative colitis	3.45e-05	0.000241	CcSEcCtD
Ofloxacin—Anaphylactic shock—Dexamethasone—ulcerative colitis	3.45e-05	0.000241	CcSEcCtD
Ofloxacin—Insomnia—Triamcinolone—ulcerative colitis	3.44e-05	0.00024	CcSEcCtD
Ofloxacin—Insomnia—Methylprednisolone—ulcerative colitis	3.43e-05	0.00024	CcSEcCtD
Ofloxacin—Infection—Dexamethasone—ulcerative colitis	3.43e-05	0.000239	CcSEcCtD
Ofloxacin—Infection—Betamethasone—ulcerative colitis	3.43e-05	0.000239	CcSEcCtD
Ofloxacin—Ill-defined disorder—Prednisone—ulcerative colitis	3.41e-05	0.000239	CcSEcCtD
Ofloxacin—Paraesthesia—Triamcinolone—ulcerative colitis	3.41e-05	0.000238	CcSEcCtD
Ofloxacin—Feeling abnormal—Prednisolone—ulcerative colitis	3.4e-05	0.000238	CcSEcCtD
Ofloxacin—Paraesthesia—Methylprednisolone—ulcerative colitis	3.4e-05	0.000238	CcSEcCtD
Ofloxacin—Anaemia—Prednisone—ulcerative colitis	3.4e-05	0.000238	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	3.39e-05	0.00119	CbGpPWpGaD
Ofloxacin—Shock—Dexamethasone—ulcerative colitis	3.39e-05	0.000237	CcSEcCtD
Ofloxacin—Shock—Betamethasone—ulcerative colitis	3.39e-05	0.000237	CcSEcCtD
Ofloxacin—Dyspnoea—Triamcinolone—ulcerative colitis	3.39e-05	0.000237	CcSEcCtD
Ofloxacin—Nervous system disorder—Dexamethasone—ulcerative colitis	3.38e-05	0.000236	CcSEcCtD
Ofloxacin—Nervous system disorder—Betamethasone—ulcerative colitis	3.38e-05	0.000236	CcSEcCtD
Ofloxacin—Agitation—Prednisone—ulcerative colitis	3.38e-05	0.000236	CcSEcCtD
Ofloxacin—Thrombocytopenia—Betamethasone—ulcerative colitis	3.38e-05	0.000236	CcSEcCtD
Ofloxacin—Thrombocytopenia—Dexamethasone—ulcerative colitis	3.38e-05	0.000236	CcSEcCtD
Ofloxacin—Nausea—Mesalazine—ulcerative colitis	3.37e-05	0.000236	CcSEcCtD
Ofloxacin—Tachycardia—Betamethasone—ulcerative colitis	3.36e-05	0.000235	CcSEcCtD
Ofloxacin—Tachycardia—Dexamethasone—ulcerative colitis	3.36e-05	0.000235	CcSEcCtD
Ofloxacin—Angioedema—Prednisone—ulcerative colitis	3.36e-05	0.000235	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	3.35e-05	0.00117	CbGpPWpGaD
Ofloxacin—Dyspepsia—Triamcinolone—ulcerative colitis	3.34e-05	0.000234	CcSEcCtD
Ofloxacin—Dyspepsia—Methylprednisolone—ulcerative colitis	3.34e-05	0.000233	CcSEcCtD
Ofloxacin—Hyperhidrosis—Betamethasone—ulcerative colitis	3.33e-05	0.000233	CcSEcCtD
Ofloxacin—Hyperhidrosis—Dexamethasone—ulcerative colitis	3.33e-05	0.000233	CcSEcCtD
Ofloxacin—Feeling abnormal—Hydrocortisone—ulcerative colitis	3.33e-05	0.000232	CcSEcCtD
Ofloxacin—Malaise—Prednisone—ulcerative colitis	3.32e-05	0.000232	CcSEcCtD
Ofloxacin—Vertigo—Prednisone—ulcerative colitis	3.31e-05	0.000231	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	3.3e-05	0.000231	CcSEcCtD
Ofloxacin—Syncope—Prednisone—ulcerative colitis	3.3e-05	0.000231	CcSEcCtD
Ofloxacin—Anorexia—Dexamethasone—ulcerative colitis	3.29e-05	0.00023	CcSEcCtD
Ofloxacin—Anorexia—Betamethasone—ulcerative colitis	3.29e-05	0.00023	CcSEcCtD
Ofloxacin—Urticaria—Prednisolone—ulcerative colitis	3.28e-05	0.000229	CcSEcCtD
Ofloxacin—Fatigue—Triamcinolone—ulcerative colitis	3.28e-05	0.000229	CcSEcCtD
Ofloxacin—Fatigue—Methylprednisolone—ulcerative colitis	3.27e-05	0.000228	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	3.26e-05	0.00115	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—DLD—ulcerative colitis	3.26e-05	0.00115	CbGpPWpGaD
Ofloxacin—Pain—Triamcinolone—ulcerative colitis	3.25e-05	0.000227	CcSEcCtD
Ofloxacin—Loss of consciousness—Prednisone—ulcerative colitis	3.23e-05	0.000226	CcSEcCtD
Ofloxacin—Hypotension—Betamethasone—ulcerative colitis	3.22e-05	0.000225	CcSEcCtD
Ofloxacin—Hypotension—Dexamethasone—ulcerative colitis	3.22e-05	0.000225	CcSEcCtD
Ofloxacin—ABCC1—Disease—LTF—ulcerative colitis	3.22e-05	0.00113	CbGpPWpGaD
Ofloxacin—Urticaria—Hydrocortisone—ulcerative colitis	3.21e-05	0.000224	CcSEcCtD
Ofloxacin—Body temperature increased—Hydrocortisone—ulcerative colitis	3.19e-05	0.000223	CcSEcCtD
Ofloxacin—Abdominal pain—Hydrocortisone—ulcerative colitis	3.19e-05	0.000223	CcSEcCtD
Ofloxacin—Hypertension—Prednisone—ulcerative colitis	3.18e-05	0.000222	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	3.17e-05	0.00111	CbGpPWpGaD
Ofloxacin—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	3.14e-05	0.000219	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	3.14e-05	0.000219	CcSEcCtD
Ofloxacin—Myalgia—Prednisone—ulcerative colitis	3.13e-05	0.000219	CcSEcCtD
Ofloxacin—Arthralgia—Prednisone—ulcerative colitis	3.13e-05	0.000219	CcSEcCtD
Ofloxacin—Feeling abnormal—Triamcinolone—ulcerative colitis	3.13e-05	0.000219	CcSEcCtD
Ofloxacin—Feeling abnormal—Methylprednisolone—ulcerative colitis	3.12e-05	0.000218	CcSEcCtD
Ofloxacin—Anxiety—Prednisone—ulcerative colitis	3.12e-05	0.000218	CcSEcCtD
Ofloxacin—Insomnia—Dexamethasone—ulcerative colitis	3.12e-05	0.000218	CcSEcCtD
Ofloxacin—Insomnia—Betamethasone—ulcerative colitis	3.12e-05	0.000218	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	3.11e-05	0.000217	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	3.1e-05	0.000217	CcSEcCtD
Ofloxacin—Paraesthesia—Dexamethasone—ulcerative colitis	3.1e-05	0.000216	CcSEcCtD
Ofloxacin—Paraesthesia—Betamethasone—ulcerative colitis	3.1e-05	0.000216	CcSEcCtD
Ofloxacin—Discomfort—Prednisone—ulcerative colitis	3.09e-05	0.000216	CcSEcCtD
Ofloxacin—Hypersensitivity—Prednisolone—ulcerative colitis	3.04e-05	0.000213	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.04e-05	0.00107	CbGpPWpGaD
Ofloxacin—Dyspepsia—Dexamethasone—ulcerative colitis	3.03e-05	0.000212	CcSEcCtD
Ofloxacin—Dyspepsia—Betamethasone—ulcerative colitis	3.03e-05	0.000212	CcSEcCtD
Ofloxacin—SLC22A6—SLC-mediated transmembrane transport—ALB—ulcerative colitis	3.03e-05	0.00106	CbGpPWpGaD
Ofloxacin—Urticaria—Triamcinolone—ulcerative colitis	3.02e-05	0.000211	CcSEcCtD
Ofloxacin—Urticaria—Methylprednisolone—ulcerative colitis	3.01e-05	0.00021	CcSEcCtD
Ofloxacin—Body temperature increased—Triamcinolone—ulcerative colitis	3e-05	0.00021	CcSEcCtD
Ofloxacin—Anaphylactic shock—Prednisone—ulcerative colitis	3e-05	0.00021	CcSEcCtD
Ofloxacin—Oedema—Prednisone—ulcerative colitis	3e-05	0.00021	CcSEcCtD
Ofloxacin—Abdominal pain—Methylprednisolone—ulcerative colitis	3e-05	0.000209	CcSEcCtD
Ofloxacin—Decreased appetite—Betamethasone—ulcerative colitis	3e-05	0.000209	CcSEcCtD
Ofloxacin—Decreased appetite—Dexamethasone—ulcerative colitis	3e-05	0.000209	CcSEcCtD
Ofloxacin—Infection—Prednisone—ulcerative colitis	2.98e-05	0.000208	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	2.98e-05	0.000208	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Betamethasone—ulcerative colitis	2.98e-05	0.000208	CcSEcCtD
Ofloxacin—Hypersensitivity—Hydrocortisone—ulcerative colitis	2.97e-05	0.000208	CcSEcCtD
Ofloxacin—Fatigue—Betamethasone—ulcerative colitis	2.97e-05	0.000208	CcSEcCtD
Ofloxacin—Fatigue—Dexamethasone—ulcerative colitis	2.97e-05	0.000208	CcSEcCtD
Ofloxacin—Shock—Prednisone—ulcerative colitis	2.95e-05	0.000206	CcSEcCtD
Ofloxacin—Pain—Betamethasone—ulcerative colitis	2.95e-05	0.000206	CcSEcCtD
Ofloxacin—Pain—Dexamethasone—ulcerative colitis	2.95e-05	0.000206	CcSEcCtD
Ofloxacin—ABCC2—NRF2 pathway—TGFB1—ulcerative colitis	2.95e-05	0.00103	CbGpPWpGaD
Ofloxacin—Nervous system disorder—Prednisone—ulcerative colitis	2.94e-05	0.000206	CcSEcCtD
Ofloxacin—Tachycardia—Prednisone—ulcerative colitis	2.93e-05	0.000205	CcSEcCtD
Ofloxacin—Skin disorder—Prednisone—ulcerative colitis	2.92e-05	0.000204	CcSEcCtD
Ofloxacin—Hyperhidrosis—Prednisone—ulcerative colitis	2.9e-05	0.000203	CcSEcCtD
Ofloxacin—Asthenia—Hydrocortisone—ulcerative colitis	2.9e-05	0.000202	CcSEcCtD
Ofloxacin—Anorexia—Prednisone—ulcerative colitis	2.86e-05	0.0002	CcSEcCtD
Ofloxacin—Pruritus—Hydrocortisone—ulcerative colitis	2.85e-05	0.0002	CcSEcCtD
Ofloxacin—Feeling abnormal—Dexamethasone—ulcerative colitis	2.84e-05	0.000199	CcSEcCtD
Ofloxacin—Feeling abnormal—Betamethasone—ulcerative colitis	2.84e-05	0.000199	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Betamethasone—ulcerative colitis	2.82e-05	0.000197	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Dexamethasone—ulcerative colitis	2.82e-05	0.000197	CcSEcCtD
Ofloxacin—Hypersensitivity—Triamcinolone—ulcerative colitis	2.8e-05	0.000196	CcSEcCtD
Ofloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.79e-05	0.000981	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Methylprednisolone—ulcerative colitis	2.79e-05	0.000195	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	2.79e-05	0.000978	CbGpPWpGaD
Ofloxacin—Diarrhoea—Hydrocortisone—ulcerative colitis	2.76e-05	0.000193	CcSEcCtD
Ofloxacin—Urticaria—Betamethasone—ulcerative colitis	2.74e-05	0.000191	CcSEcCtD
Ofloxacin—Urticaria—Dexamethasone—ulcerative colitis	2.74e-05	0.000191	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Prednisone—ulcerative colitis	2.74e-05	0.000191	CcSEcCtD
Ofloxacin—Dizziness—Prednisolone—ulcerative colitis	2.73e-05	0.000191	CcSEcCtD
Ofloxacin—Asthenia—Triamcinolone—ulcerative colitis	2.73e-05	0.000191	CcSEcCtD
Ofloxacin—Body temperature increased—Dexamethasone—ulcerative colitis	2.73e-05	0.00019	CcSEcCtD
Ofloxacin—Abdominal pain—Betamethasone—ulcerative colitis	2.73e-05	0.00019	CcSEcCtD
Ofloxacin—Body temperature increased—Betamethasone—ulcerative colitis	2.73e-05	0.00019	CcSEcCtD
Ofloxacin—Abdominal pain—Dexamethasone—ulcerative colitis	2.73e-05	0.00019	CcSEcCtD
Ofloxacin—Asthenia—Methylprednisolone—ulcerative colitis	2.72e-05	0.00019	CcSEcCtD
Ofloxacin—SLC22A4—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.72e-05	0.000953	CbGpPWpGaD
Ofloxacin—Insomnia—Prednisone—ulcerative colitis	2.72e-05	0.00019	CcSEcCtD
Ofloxacin—Paraesthesia—Prednisone—ulcerative colitis	2.7e-05	0.000188	CcSEcCtD
Ofloxacin—Pruritus—Triamcinolone—ulcerative colitis	2.69e-05	0.000188	CcSEcCtD
Ofloxacin—TOP2A—Circadian rythm related genes—TP53—ulcerative colitis	2.68e-05	0.000942	CbGpPWpGaD
Ofloxacin—Pruritus—Methylprednisolone—ulcerative colitis	2.68e-05	0.000187	CcSEcCtD
Ofloxacin—Dizziness—Hydrocortisone—ulcerative colitis	2.67e-05	0.000186	CcSEcCtD
Ofloxacin—Dyspepsia—Prednisone—ulcerative colitis	2.64e-05	0.000185	CcSEcCtD
Ofloxacin—Decreased appetite—Prednisone—ulcerative colitis	2.61e-05	0.000182	CcSEcCtD
Ofloxacin—Rash—Prednisolone—ulcerative colitis	2.61e-05	0.000182	CcSEcCtD
Ofloxacin—Dermatitis—Prednisolone—ulcerative colitis	2.6e-05	0.000182	CcSEcCtD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	2.6e-05	0.000914	CbGpPWpGaD
Ofloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	2.6e-05	0.000914	CbGpPWpGaD
Ofloxacin—Diarrhoea—Methylprednisolone—ulcerative colitis	2.59e-05	0.000181	CcSEcCtD
Ofloxacin—Fatigue—Prednisone—ulcerative colitis	2.59e-05	0.000181	CcSEcCtD
Ofloxacin—Headache—Prednisolone—ulcerative colitis	2.59e-05	0.000181	CcSEcCtD
Ofloxacin—Constipation—Prednisone—ulcerative colitis	2.57e-05	0.000179	CcSEcCtD
Ofloxacin—Vomiting—Hydrocortisone—ulcerative colitis	2.57e-05	0.000179	CcSEcCtD
Ofloxacin—Rash—Hydrocortisone—ulcerative colitis	2.54e-05	0.000178	CcSEcCtD
Ofloxacin—Dermatitis—Hydrocortisone—ulcerative colitis	2.54e-05	0.000178	CcSEcCtD
Ofloxacin—Headache—Hydrocortisone—ulcerative colitis	2.53e-05	0.000177	CcSEcCtD
Ofloxacin—Dizziness—Triamcinolone—ulcerative colitis	2.51e-05	0.000176	CcSEcCtD
Ofloxacin—Dizziness—Methylprednisolone—ulcerative colitis	2.51e-05	0.000175	CcSEcCtD
Ofloxacin—Feeling abnormal—Prednisone—ulcerative colitis	2.47e-05	0.000173	CcSEcCtD
Ofloxacin—Asthenia—Betamethasone—ulcerative colitis	2.47e-05	0.000173	CcSEcCtD
Ofloxacin—Asthenia—Dexamethasone—ulcerative colitis	2.47e-05	0.000173	CcSEcCtD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.46e-05	0.000865	CbGpPWpGaD
Ofloxacin—TOP2A—Circadian rythm related genes—IL6—ulcerative colitis	2.46e-05	0.000862	CbGpPWpGaD
Ofloxacin—Gastrointestinal pain—Prednisone—ulcerative colitis	2.46e-05	0.000172	CcSEcCtD
Ofloxacin—Nausea—Prednisolone—ulcerative colitis	2.45e-05	0.000172	CcSEcCtD
Ofloxacin—Pruritus—Dexamethasone—ulcerative colitis	2.44e-05	0.00017	CcSEcCtD
Ofloxacin—Pruritus—Betamethasone—ulcerative colitis	2.44e-05	0.00017	CcSEcCtD
Ofloxacin—Vomiting—Triamcinolone—ulcerative colitis	2.42e-05	0.000169	CcSEcCtD
Ofloxacin—Vomiting—Methylprednisolone—ulcerative colitis	2.41e-05	0.000168	CcSEcCtD
Ofloxacin—Nausea—Hydrocortisone—ulcerative colitis	2.4e-05	0.000167	CcSEcCtD
Ofloxacin—Rash—Triamcinolone—ulcerative colitis	2.4e-05	0.000167	CcSEcCtD
Ofloxacin—Dermatitis—Triamcinolone—ulcerative colitis	2.39e-05	0.000167	CcSEcCtD
Ofloxacin—Rash—Methylprednisolone—ulcerative colitis	2.39e-05	0.000167	CcSEcCtD
Ofloxacin—Dermatitis—Methylprednisolone—ulcerative colitis	2.39e-05	0.000167	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.39e-05	0.000838	CbGpPWpGaD
Ofloxacin—Urticaria—Prednisone—ulcerative colitis	2.39e-05	0.000167	CcSEcCtD
Ofloxacin—Headache—Triamcinolone—ulcerative colitis	2.38e-05	0.000166	CcSEcCtD
Ofloxacin—Headache—Methylprednisolone—ulcerative colitis	2.38e-05	0.000166	CcSEcCtD
Ofloxacin—Body temperature increased—Prednisone—ulcerative colitis	2.37e-05	0.000166	CcSEcCtD
Ofloxacin—Abdominal pain—Prednisone—ulcerative colitis	2.37e-05	0.000166	CcSEcCtD
Ofloxacin—Diarrhoea—Dexamethasone—ulcerative colitis	2.36e-05	0.000165	CcSEcCtD
Ofloxacin—Diarrhoea—Betamethasone—ulcerative colitis	2.36e-05	0.000165	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ABCB1—ulcerative colitis	2.36e-05	0.000828	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.3e-05	0.000807	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—SLC11A1—ulcerative colitis	2.29e-05	0.000804	CbGpPWpGaD
Ofloxacin—Dizziness—Betamethasone—ulcerative colitis	2.28e-05	0.000159	CcSEcCtD
Ofloxacin—Dizziness—Dexamethasone—ulcerative colitis	2.28e-05	0.000159	CcSEcCtD
Ofloxacin—Nausea—Triamcinolone—ulcerative colitis	2.26e-05	0.000158	CcSEcCtD
Ofloxacin—Nausea—Methylprednisolone—ulcerative colitis	2.25e-05	0.000157	CcSEcCtD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.23e-05	0.000781	CbGpPWpGaD
Ofloxacin—Hypersensitivity—Prednisone—ulcerative colitis	2.21e-05	0.000155	CcSEcCtD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	2.2e-05	0.000772	CbGpPWpGaD
Ofloxacin—Vomiting—Betamethasone—ulcerative colitis	2.19e-05	0.000153	CcSEcCtD
Ofloxacin—Vomiting—Dexamethasone—ulcerative colitis	2.19e-05	0.000153	CcSEcCtD
Ofloxacin—Rash—Betamethasone—ulcerative colitis	2.17e-05	0.000152	CcSEcCtD
Ofloxacin—Rash—Dexamethasone—ulcerative colitis	2.17e-05	0.000152	CcSEcCtD
Ofloxacin—Dermatitis—Dexamethasone—ulcerative colitis	2.17e-05	0.000152	CcSEcCtD
Ofloxacin—Dermatitis—Betamethasone—ulcerative colitis	2.17e-05	0.000152	CcSEcCtD
Ofloxacin—Headache—Dexamethasone—ulcerative colitis	2.16e-05	0.000151	CcSEcCtD
Ofloxacin—Headache—Betamethasone—ulcerative colitis	2.16e-05	0.000151	CcSEcCtD
Ofloxacin—Asthenia—Prednisone—ulcerative colitis	2.15e-05	0.000151	CcSEcCtD
Ofloxacin—Pruritus—Prednisone—ulcerative colitis	2.12e-05	0.000148	CcSEcCtD
Ofloxacin—ABCC1—Disease—MAML2—ulcerative colitis	2.06e-05	0.000723	CbGpPWpGaD
Ofloxacin—Diarrhoea—Prednisone—ulcerative colitis	2.05e-05	0.000144	CcSEcCtD
Ofloxacin—Nausea—Betamethasone—ulcerative colitis	2.05e-05	0.000143	CcSEcCtD
Ofloxacin—Nausea—Dexamethasone—ulcerative colitis	2.05e-05	0.000143	CcSEcCtD
Ofloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.04e-05	0.000717	CbGpPWpGaD
Ofloxacin—Dizziness—Prednisone—ulcerative colitis	1.99e-05	0.000139	CcSEcCtD
Ofloxacin—Vomiting—Prednisone—ulcerative colitis	1.91e-05	0.000133	CcSEcCtD
Ofloxacin—Rash—Prednisone—ulcerative colitis	1.89e-05	0.000132	CcSEcCtD
Ofloxacin—Dermatitis—Prednisone—ulcerative colitis	1.89e-05	0.000132	CcSEcCtD
Ofloxacin—Headache—Prednisone—ulcerative colitis	1.88e-05	0.000131	CcSEcCtD
Ofloxacin—Nausea—Prednisone—ulcerative colitis	1.78e-05	0.000125	CcSEcCtD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.73e-05	0.000606	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CALM3—ulcerative colitis	1.7e-05	0.000595	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS1—ulcerative colitis	1.58e-05	0.000554	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.55e-05	0.000545	CbGpPWpGaD
Ofloxacin—SLC22A6—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.54e-05	0.000541	CbGpPWpGaD
Ofloxacin—ABCC2—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.49e-05	0.000524	CbGpPWpGaD
Ofloxacin—ABCC1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.47e-05	0.000518	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.44e-05	0.000504	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—CALM3—ulcerative colitis	1.42e-05	0.000499	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.36e-05	0.000476	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.34e-05	0.000472	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—DLD—ulcerative colitis	1.24e-05	0.000435	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—ADCY5—ulcerative colitis	1.23e-05	0.000432	CbGpPWpGaD
Ofloxacin—TOP2A—Cell Cycle—TP53—ulcerative colitis	1.21e-05	0.000425	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ABCB1—ulcerative colitis	1.1e-05	0.000388	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ADCY5—ulcerative colitis	1.03e-05	0.000362	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PPARG—ulcerative colitis	7.68e-06	0.00027	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—JAK2—ulcerative colitis	7.67e-06	0.000269	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—CD4—ulcerative colitis	7.27e-06	0.000255	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—PTGS2—ulcerative colitis	7.22e-06	0.000253	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—ALB—ulcerative colitis	6.91e-06	0.000243	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.55e-06	0.00023	CbGpPWpGaD
Ofloxacin—ABCC1—Metabolism—PTGS2—ulcerative colitis	6.04e-06	0.000212	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS1—ulcerative colitis	5.99e-06	0.00021	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.89e-06	0.000207	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—STAT3—ulcerative colitis	5.63e-06	0.000198	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—CALM3—ulcerative colitis	5.39e-06	0.000189	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—TGFB1—ulcerative colitis	5.22e-06	0.000183	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.15e-06	0.000181	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ABCB1—ulcerative colitis	4.19e-06	0.000147	CbGpPWpGaD
Ofloxacin—ABCC1—Disease—IL6—ulcerative colitis	3.93e-06	0.000138	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ADCY5—ulcerative colitis	3.91e-06	0.000137	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PPARG—ulcerative colitis	2.92e-06	0.000102	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—ALB—ulcerative colitis	2.62e-06	9.21e-05	CbGpPWpGaD
Ofloxacin—CYP1A2—Metabolism—PTGS2—ulcerative colitis	2.3e-06	8.06e-05	CbGpPWpGaD
